The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.
Dubai Ruler praises record Egyptian readers in Arab challenge
UAE leaders mark Hijri New Year with messages of optimism and prosperity
ത്തയിലെ മലനിരകളിൽ കുടുങ്ങിയ ഹൈക്കറെ രക്ഷപ്പെടുത്തി ദുബായ് പോലീസ്
Global coalition condemns drone attack near UAE’s Barakah nuclear plant
യുഎസ്-ഇറാൻ കരാർ; നയതന്ത്രത്തിന് ഊന്നൽ നൽകി യുഎഇ
UAE stresses on diplomacy and dialogue as US, Iran reach agreement to end war
അൽ മക്തൂം അന്താരാഷ്ട്ര വിമാനത്താവള വിപുലീകരണ പദ്ധതി; ആദ്യ ഘട്ടം 2032 ൽ പൂർത്തിയാകും.
UAE President discusses regional developments with Egypt counterpart
